AI-Driven Design Platforms of Next-Generation Antibody Therapeutics
{{output}}
Artificial intelligence (AI) is reshaping drug discovery by bridging the gap between traditional computer-aided drug design (CADD) and next-generation, data-driven methodologies. Unlike conventional CADD, which relies on physical modelling of molecular interac... ...
